PLIANT THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $24.9M | $22.2M | $45.4M | $93.7M | $86.8M | $91.9M | $71.2M | $79.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $163.1M | $174.9M | $196.4M | $245.6M | $267.4M | $311.2M | $362.3M | $410.0M |
| Property, Plant & Equipment | $2.4M | $2.7M | $2.9M | $4.3M | $4.9M | $5.2M | $5.5M | $5.7M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $189.9M | $202.6M | $225.2M | $276.6M | $299.8M | $344.8M | $396.9M | $445.7M |
| Liabilities | ||||||||
| Accounts Payable | $1.5M | $362.0K | $480.0K | $485.0K | $1.4M | $5.6M | $6.0M | $6.9M |
| Total Current Liabilities | $16.5M | $10.4M | $16.4M | $17.6M | $20.6M | $28.2M | $33.2M | $40.0M |
| Long-Term Debt | $0 | $0 | $0 | $30.4M | $30.4M | $30.3M | $30.2M | $30.1M |
| Total Liabilities | $43.0M | $37.4M | $44.0M | $76.3M | $79.7M | $87.6M | $92.9M | $99.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-901.8M | $-879.4M | $-859.4M | $-835.8M | $-809.5M | $-766.2M | $-710.1M | $-660.3M |
| Total Stockholders' Equity | $146.9M | $165.2M | $181.2M | $200.3M | $220.1M | $257.2M | $304.1M | $345.8M |